Literature DB >> 12165375

Increased duration of illness is associated with reduced volume in right medial temporal/anterior cingulate grey matter in patients with chronic schizophrenia.

Dennis Velakoulis1, Stephen J Wood, Deidre J Smith, Bridget Soulsby, Warrick Brewer, Liz Leeton, Patricia Desmond, John Suckling, Edward T Bullmore, Philip K McGuire, Christos Pantelis.   

Abstract

It is unclear whether the neuroanatomical abnormalities associated with schizophrenia change over the course of the disorder. We addressed this issue by examining whether the magnitude of structural brain abnormalities in patients with chronic schizophrenia was related to their duration of illness. Thirty-nine subjects with schizophrenia (34 male, 5 female, range of illness duration 2-31 years) were scanned using magnetic resonance imaging. Images were segmented into grey and white matter, cerebrospinal fluid and dura/blood vessels using the Structural Magnetic Resonance Toolkit (SMaRT). Voxel-based analysis identified brain areas whose volume varied significantly with time since the first onset of psychosis. Right medial temporal, medial cerebellar and bilateral anterior cingulate grey matter volume, and white matter volume in the right posterior limb of the internal capsule, were all negatively correlated with illness duration (p < 0.002). Conversely, illness duration was positively correlated with the volume of the right globus pallidus (p < 0.002). These correlations were not a function of chronological age or age at illness onset. The inverse correlation between right frontal, temporal and cerebellar volumes and the time since the onset of schizophrenia could reflect progressive tissue loss following the first episode of the disorder. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Year:  2002        PMID: 12165375     DOI: 10.1016/s0920-9964(01)00307-3

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  12 in total

1.  Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.

Authors:  Tatsunobu Natsubori; Hideyuki Inoue; Osamu Abe; Yosuke Takano; Norichika Iwashiro; Yuta Aoki; Shinsuke Koike; Noriaki Yahata; Masaki Katsura; Wataru Gonoi; Hiroki Sasaki; Hidemasa Takao; Kiyoto Kasai; Hidenori Yamasue
Journal:  Schizophr Bull       Date:  2013-09-10       Impact factor: 9.306

2.  Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness.

Authors:  Päivikki Tanskanen; Khanum Ridler; Graham K Murray; Marianne Haapea; Juha M Veijola; Erika Jääskeläinen; Jouko Miettunen; Peter B Jones; Edward T Bullmore; Matti K Isohanni
Journal:  Schizophr Bull       Date:  2008-11-17       Impact factor: 9.306

3.  Functional dysconnectivity in schizophrenia associated with attentional modulation of motor function.

Authors:  Garry D Honey; Edith Pomarol-Clotet; Philip R Corlett; Rebekah A E Honey; Peter J McKenna; Edward T Bullmore; Paul C Fletcher
Journal:  Brain       Date:  2005-09-23       Impact factor: 13.501

4.  The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample.

Authors:  Murat Yücel; Emre Bora; Dan I Lubman; Nadia Solowij; Warrick J Brewer; Sue M Cotton; Philippe Conus; Michael J Takagi; Alex Fornito; Stephen J Wood; Patrick D McGorry; Christos Pantelis
Journal:  Schizophr Bull       Date:  2010-07-25       Impact factor: 9.306

5.  Right-hemisphere encephalopathy in elderly subjects with schizophrenia: evidence from neuropsychological and brain imaging studies.

Authors:  V S Gabrovska-Johnson; M Scott; S Jeffries; N Thacker; R C Baldwin; A Burns; S W Lewis; J F W Deakin
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

6.  Untreated illness duration correlates with gray matter loss in first-episode psychoses.

Authors:  Srihari S Bangalore; Dhruman D Goradia; Jeffrey Nutche; Vaibhav A Diwadkar; Konasale M R Prasad; Matcheri S Keshavan
Journal:  Neuroreport       Date:  2009-05-06       Impact factor: 1.837

7.  In vivo 7 Tesla imaging of the dentate granule cell layer in schizophrenia.

Authors:  Ivan I Kirov; Caitlin J Hardy; Kant Matsuda; Julie Messinger; Ceylan Z Cankurtaran; Melina Warren; Graham C Wiggins; Nissa N Perry; James S Babb; Raymond R Goetz; Ajax George; Dolores Malaspina; Oded Gonen
Journal:  Schizophr Res       Date:  2013-05-10       Impact factor: 4.939

8.  Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia.

Authors:  Beng-Choon Ho; Nancy C Andreasen; Jeffrey D Dawson; Thomas H Wassink
Journal:  Am J Psychiatry       Date:  2007-12       Impact factor: 18.112

9.  Neuropsychological testing and structural magnetic resonance imaging as diagnostic biomarkers early in the course of schizophrenia and related psychoses.

Authors:  Elissaios Karageorgiou; S Charles Schulz; Randy L Gollub; Nancy C Andreasen; Beng-Choon Ho; John Lauriello; Vince D Calhoun; H Jeremy Bockholt; Scott R Sponheim; Apostolos P Georgopoulos
Journal:  Neuroinformatics       Date:  2011-12

10.  White matter microstructure in schizophrenia: effects of disorder, duration and medication.

Authors:  Richard Kanaan; Gareth Barker; Michael Brammer; Vincent Giampietro; Sukhwinder Shergill; James Woolley; Marco Picchioni; Timothea Toulopoulou; Philip McGuire
Journal:  Br J Psychiatry       Date:  2009-03       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.